118 related articles for article (PubMed ID: 10092477)
1. Failure of highly immunogenic filarial proteins to provide host-protective immunity.
Peralta ME; Schmitz KA; Rajan TV
Exp Parasitol; 1999 Apr; 91(4):334-40. PubMed ID: 10092477
[TBL] [Abstract][Full Text] [Related]
2. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.
Thirugnanam S; Pandiaraja P; Ramaswamy K; Murugan V; Gnanasekar M; Nandakumar K; Reddy MV; Kaliraj P
Exp Parasitol; 2007 Aug; 116(4):483-91. PubMed ID: 17442307
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylactic evaluation of a 37-kDa Brugia malayi recombinant antigen in lymphatic filariasis.
Dabir P; Dabir S; Krithika KN; Goswami K; Reddy MV
Clin Microbiol Infect; 2006 Apr; 12(4):361-8. PubMed ID: 16524413
[TBL] [Abstract][Full Text] [Related]
4. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.
Gregory WF; Atmadja AK; Allen JE; Maizels RM
Infect Immun; 2000 Jul; 68(7):4174-9. PubMed ID: 10858234
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.
Veerapathran A; Dakshinamoorthy G; Gnanasekar M; Reddy MV; Kalyanasundaram R
PLoS Negl Trop Dis; 2009 Jun; 3(6):e457. PubMed ID: 19513102
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Brugia malayi pepsin inhibitor (rBm33) exploits host signaling events to regulate inflammatory responses associated with lymphatic filarial infections.
Sreenivas K; Kalyanaraman H; Babu S; Narayanan RB
Microb Pathog; 2017 Nov; 112():195-208. PubMed ID: 28942176
[TBL] [Abstract][Full Text] [Related]
7. Myosin heavy chain is a dominant parasite antigen recognized by antibodies in sera from donors with filarial infections.
Dissanayake S; Xu M; Piessens WF
Mol Biochem Parasitol; 1992 Dec; 56(2):349-51. PubMed ID: 1484558
[No Abstract] [Full Text] [Related]
8. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis.
Joseph SK; Ramaswamy K
Vaccine; 2013 Jul; 31(33):3320-6. PubMed ID: 23735679
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to somatic L3 antigen not protective against Brugia malayi infection.
Noordin R; Abdullah KA; Azahri NA; Ramachandran CP
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):678-81. PubMed ID: 10928359
[TBL] [Abstract][Full Text] [Related]
10. Repeat region of Brugia malayi sheath protein (Shp-1) carries Dominant B epitopes recognized in filarial endemic population.
Jawaharlal JP; Madhumathi J; Prince RP; Kaliraj P
Acta Parasitol; 2014 Sep; 59(3):454-8. PubMed ID: 25119360
[TBL] [Abstract][Full Text] [Related]
11. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds.
Anand SB; Kodumudi KN; Reddy MV; Kaliraj P
J Helminthol; 2011 Dec; 85(4):442-52. PubMed ID: 21208482
[TBL] [Abstract][Full Text] [Related]
12. Chimeric Epitope Vaccine from Multistage Antigens for Lymphatic Filariasis.
Anugraha G; Madhumathi J; Prince PR; Prita PJ; Khatri VK; Amdare NP; Reddy MV; Kaliraj P
Scand J Immunol; 2015 Oct; 82(4):380-9. PubMed ID: 26179420
[TBL] [Abstract][Full Text] [Related]
13. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia.
Jha R; Gangwar M; Chahar D; Setty Balakrishnan A; Negi MP; Misra-Bhattacharya S
Parasit Vectors; 2017 Jan; 10(1):40. PubMed ID: 28118850
[TBL] [Abstract][Full Text] [Related]
14. The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination.
Ramachandran S; Kumar MP; Rami RM; Chinnaiah HB; Nutman T; Kaliraj P; McCarthy J
Microbiol Immunol; 2004; 48(12):945-55. PubMed ID: 15611611
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.
Dakshinamoorthy G; Kalyanasundaram R
Vaccine; 2013 Dec; 32(1):19-25. PubMed ID: 24211167
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis.
Dakshinamoorthy G; Samykutty AK; Munirathinam G; Shinde GB; Nutman T; Reddy MV; Kalyanasundaram R
PLoS One; 2012; 7(4):e34077. PubMed ID: 22496777
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P
Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232
[TBL] [Abstract][Full Text] [Related]
18. Immune responses of B. malayi thioredoxin (TRX) and venom allergen homologue (VAH) chimeric multiple antigen for lymphatic filariasis.
Anugraha G; Jeyaprita PJ; Madhumathi J; Sheeba T; Kaliraj P
Acta Parasitol; 2013 Dec; 58(4):468-77. PubMed ID: 24338307
[TBL] [Abstract][Full Text] [Related]
19. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.
Gnanasekar M; Rao KV; He YX; Mishra PK; Nutman TB; Kaliraj P; Ramaswamy K
Infect Immun; 2004 Aug; 72(8):4707-15. PubMed ID: 15271932
[TBL] [Abstract][Full Text] [Related]
20. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates.
Khatri V; Chauhan N; Vishnoi K; von Gegerfelt A; Gittens C; Kalyanasundaram R
Int J Parasitol; 2018 Aug; 48(9-10):773-783. PubMed ID: 29885437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
